Centene Corporation Underwriting AgreementUnderwriting Agreement • June 14th, 2016 • Centene Corp • Hospital & medical service plans • New York
Centene Corporation, a Delaware corporation (the “Company”), proposes to issue and sell $500,000,000 aggregate principal amount of its 4.75% Senior Notes due 2022 (the “Notes”) to the several underwriters named on Schedule I hereto (the “Underwriters”), for which Citigroup Global Markets Inc., Barclays Capital Inc., SunTrust Robinson Humphrey, Inc., and Wells Fargo Securities, LLC are acting as representatives (the “Representatives”). The Notes will be issued pursuant to the indenture (the “Indenture”) dated as of April 29, 2014 between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”). On April 29, 2014 and January 14, 2015, the Company issued $300,000,000 and $200,000,000, respectively, aggregate principal amount of the Company’s 4.75% Senior Notes due 2022 (collectively, the “Existing Notes”), in each case under the Indenture. The Notes constitute an offering of “Additional Notes” (as such term is defined in the Indenture) under the Indentur
